- After closing its borders to international visitors for 20 months due to the pandemic, India will now allow fully vaccinated foreign travelers from a list of nearly 100 countries to enter without the need for quarantine.
- As of 13 November, there were 99 countries on that list including the United States, the UK, Singapore, Australia, Germany, France and Brazil.
After closing its borders to international visitors for 20 months due to the pandemic, India will now allow fully vaccinated foreign travelers from a list of nearly 100 countries to enter without the need for quarantine.
In Guidelines updated last weekIndia said that travelers arriving from these countries would be allowed to skip post-arrival COVID testing, but they would have to monitor their health for the next 14 days.
By November 13, there were 99 countries on that list Including the USA, UK, Singapore, Australia, Germany, France and Brazil.
The countries included in the list fall into two categories:
1. With mutual agreement with the Government of India to recognize each other’s vaccine certificates for either locally approved vaccines or vaccines recognized by the World Health Organization;
2. And countries that do not have such agreements but which allow fully vaccinated Indian nationals to travel.
Visitors from countries that are not on the list will have to undergo a COVID test upon arrival, then spend 7 days in home quarantine and another test on the 8th day, regardless of their vaccination status.
Notable countries missing from that list of 99 include China, Japan, South Korea and Indonesia.
India experienced a devastating second wave that peaked in early May. It pushed the country’s health care system to the brink as Covid-19 cases soared and hospital beds and other medical supplies ran out. Since then, cases have been declining while vaccination rates have increased somewhat.
Information gathered by the online publication, Our World in Data revealed that 7-day rolling average of COVID cases per million people It fell below 10 on 31 October and remained that way until 14 November. At its peak in May, the number was as high as 280.
Nevertheless, due to limited testing, the number of confirmed cases is less than the actual number of infections.
Last month, India reached a remarkable vaccine milestone – it administered over 1 billion COVID-19 vaccine doses since launching its ambitious immunization program in January.
Even then, Only less than 40% of the eligible population Fully vaccinated, falling below the pace needed to meet New Delhi’s needs previously declared target To vaccinate every adult by the end of the year.
India has approved several vaccines since starting the vaccination programme. These include the vaccine developed by AstraZeneca and the University of Oxford – known locally as Covishield and manufactured by the Serum Institute – as well as Bharat Biotech’s Covaxin, and Russia’s Sputnik-V.
Both Covishield and Covaxin are approved by the World Health Organization for emergency use.
India has also reportedly approved Its first vaccine for people under the age of 18 – a three-dose shot manufactured by Indian drugmaker Cadila Healthcare.